Oncology News

Although individuals in China with low-grade intraepithelial neoplasia are at higher risk for developing esophageal squamous cell carcinoma, that risk can be reduced by more than 30% with surveillance endoscopy, according to research.

The FDA has granted breakthrough device designation to Burning Rock’s OverC multicancer blood test for early detection of esophageal, liver, lung, ovarian and pancreatic cancers, according to a company press release.

Non-heavy alcohol consumption was associated with fibrosis and at-risk nonalcoholic steatohepatitis, prompting researchers to suggest that current fatty liver disease categorization as alcoholic or nonalcoholic may be “misleading.”

Multiomic analysis has provided new insights into the genetics of colorectal cancer and how genetic variants contribute to disease risk and development.

Although decision aids helped inform older adults about potential benefits and risks associated with colorectal cancer screening, the tools did not significantly influence patient preference for screening, regardless of health.

Exact Sciences announced its support for recent policy changes that aim to increase access to noninvasive colorectal cancer screening tests and require Medicare and most insurers to pay for colonoscopy after a positive stool-based test.

In 2021, an estimated 16,500 Hispanic men and women were diagnosed with cancer of the colon or rectum and about 4,700 Hispanic individuals died from the disease.

Trifluridine-tipiracil plus bevacizumab was not superior to capecitabine plus bevacizumab but presented no new safety concerns in patients with unresectable metastatic colorectal cancer who are ineligible for intensive treatment.

A plant-based diet rich in whole grains, vegetable and legumes was associated with a reduced risk for colorectal cancer in a multiethnic cohort of men but varied by race, ethnicity and site of tumor, according to research in BMC Medicine.

Zanidatamab monotherapy appeared active among patients with HER2-amplified and -expressing biliary tract cancer, according to the agent’s manufacturer.